Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxic changes to the urothelium as a bystander of end-stage bladder disease.

Journal of pediatric urology·2019
Same author

A redox state-dictated signalling pathway deciphers the malignant cell specificity of CD40-mediated apoptosis.

Oncogene·2016
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

The modulatory effect of cell–cell contact on the tumourigenic potential of pre-malignant epithelial cells: a computational exploration.

Journal of the Royal Society, Interface·2012
Same author

Surviving Sepsis and the acute medicine - critical care interface.

Acute medicine·2011
Same author

Differential display.

Methods in molecular medicine·2011

Related Experiment Video

Updated: Jun 1, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Angioedema caused by bupropion treatment.

R Bhella1, J Southgate

  • 1BM BSc FRCP (Corresponding author) Consultant Acute Physician Norfolk and Norwich University Foundation Trust Colney Lan, Norwich, NR4 7UY.

Acute Medicine
|May 21, 2011
PubMed
Summary

Bupropion, used for smoking cessation, can cause skin reactions like rash and urticaria. A rare case presented with angioedema and arthralgia, resolving with prompt treatment and drug discontinuation.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Dermatology

Background:

  • Bupropion is frequently associated with cutaneous adverse reactions, including urticaria and rash, with an incidence of 1-4%.
  • More severe adverse events such as seizures and angioedema are less common but can be dose-dependent.
  • Rarely, bupropion may trigger a serum sickness-like reaction characterized by fever, arthralgia, and myalgia.

Purpose of the Study:

  • To report a case of angioedema and arthralgia associated with bupropion use for smoking cessation.
  • To review the literature on bupropion-induced hypersensitivity reactions.
  • To discuss recommendations for safer bupropion prescribing in light of recent concerns.

Main Methods:

  • A case study of a 30-year-old male patient presenting with rash, angioedema, and arthralgia after 19 days of bupropion treatment.

More Related Videos

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
02:34

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Published on: May 10, 2024

Related Experiment Videos

Last Updated: Jun 1, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
02:34

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Published on: May 10, 2024

  • Review of existing literature on bupropion adverse effects, focusing on hypersensitivity reactions.
  • Analysis of management strategies and prescribing recommendations.
  • Main Results:

    • The patient experienced rash, angioedema, and arthralgia, consistent with a hypersensitivity reaction to bupropion.
    • Symptomatic improvement occurred within 3 hours of initiating antihistamines and steroids.
    • Complete resolution of symptoms was achieved within 3 days after discontinuing bupropion.

    Conclusions:

    • Bupropion can induce hypersensitivity reactions, including angioedema and arthralgia, which are treatable with standard medical interventions.
    • Discontinuation of the causative agent is crucial for managing bupropion-induced hypersensitivity.
    • Clinicians should be aware of the potential for serious adverse reactions and consider safer prescribing practices.